전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved47 programs
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
AntibodyLimited DatastaleAmgenPhase 2

Bemarituzumab (Bemarituzumab)

Adenocarcinoma · Gastric Cancer

#GastricCancer#Antibody#Phase2#monoclonal-antibody#Adenocarcinoma+1
Trials 2Status Active
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Preclinical

CAR-CLD18 T Cells (CAR-CLD18 T Cells)

Advanced Gastric Adenocarcinoma; Pancreatic Adenocarcinoma · Advanced Gastric Adenocarcinoma

#AdvancedGastricAdenocarcinoma#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 2Status Active
AntibodyLimited DatastaleShanghai Kechow Pharma, Inc.Phase 2

Tunlametinib+PD-1 mAb (Tunlametinib+PD-1 mAb)

Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#GastricAdenocarcinoma+1
Trials 2Status Recruiting
AntibodyLimited DatastaleShanghai Zhongshan HospitalPhase 2

nivolumab (Opdivo, Anlotinib Hydrochloride With Nivolumab)

Gastric Adenocarcinoma; Esophageal Squamous Cell Carcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#monoclonal-antibody#EsophagealSquamousCellCarcinoma+1
Trials 1Status Active
CGTLimited DatastalePromiCell Therapeutics, Inc.Phase 2

Anti-STEAP1 CAR T-cells (Anti-STEAP1 CAR T-cells)

Metastatic Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma · MET

#MET#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab + Ipatasertib)

Gastric Adenocarcinoma; Metastatic Gastric Cancer · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#monoclonal-antibody#MetastaticGastricCancer+1
Trials 1Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

Autologous T cells transfected with chimeric anti-mesothelin immunoreceptor SS1 (Autologous T cells transfected with chimeric anti-mesothelin immunoreceptor SS1)

Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA) · Subjects With Metastatic Pancreatic Duct

#SubjectsWithMetastaticPancreatic#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
ADCLimited DatastaleWest China Second University Ho…Phase 2

MRG003 (Becotatug Vedotin, Becotatug Vedotin (MRG003))

Gastric Cancer; Gastroesophageal Junction (GEJ) Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase2#antibody-drug-conjugate#GastroesophagealJunctionGEJAdeno+1
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART-meso (CART-meso)

Metastatic Pancreatic (Ductal) Adenocarcinoma; Epithelial Ovarian Cancer · Metastatic Pancreatic (Ductal) Adenocarc

#MetastaticPancreaticDuctalAdenoc#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleZhejiang Provincial People's Ho…Phase 1

CB CAR-NK18.2 (CB CAR-NK18.2)

Gastric Cancer; Pancreas Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab vedotin + Sintilimab + Multimodality radiotherapy)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#HER2-positiveAdvancedGastricCanc+1
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

MSLN + MUC1 (EB-DNK101 dual-targeting CAR-NK cells, EB-DNK101 dual-targeting CAR-NK cells (MSLN + MUC1))

Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable Locally Advanced or Metastatic Disease · Pancreatic Ductal Adenocarcinoma (PDAC)

#PancreaticDuctalAdenocarcinomaPD#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

CLDN18.2 + MUC1 (EB-DNK102 dual-targeting CAR-NK cells, EB-DNK102 dual-targeting CAR-NK cells (CLDN18.2 + MUC1))

Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable Locally Advanced or Metastatic Disease · CLDN18.2

#CLDN182#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

EB-DUO-CAR-NK-CEA/GCC (EB-DUO-CAR-NK-CEA/GCC)

Colorectal Cancer; Metastatic Colorectal Adenocarcinoma · CEA

#CEA#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleInstitut National de la Santé E…Phase 1

Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes (Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes)

Pancreatic Adenocarcinoma · Pancreatic Adenocarcinoma

#PancreaticAdenocarcinoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
AntibodyLimited DatastaleImmuneering CorporationPhase 2

Treatment Group E (IMM-1-104 + pembrolizumab, IMM-1-104 + pembrolizumab (Treatment Group E))

Advanced Solid Tumor; Pancreatic Adenocarcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#monoclonal-antibody#PancreaticAdenocarcinoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleSir Run Run Shaw HospitalPhase 2

Ipalolimab and Tovorilimab (Ipalolimab and Tovorilimab)

dMMR/MSI-H-type Rectal Adenocarcinoma · dMMR/MSI-H-type Rectal Adenocarcinoma

#dMMRMSI-H-typeRectalAdenocarcino#Antibody#Phase2#monoclonal-antibody#dMMR+2
Trials 1Status Recruiting
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LCAR-C182A cells (LCAR-C182A cells)

Gastric Cancer; Pancreatic Ductal Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
AntibodyLimited DatastaleAIO-Studien-gGmbHPhase 2

trastuzumab (Herceptin, Post-operative treatment trastuzumab mono therapy)

Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach · Adenocarcinoma of the Gastroesophageal J

#AdenocarcinomaoftheGastroesophag#Antibody#Phase2#monoclonal-antibody#AdenocarcinomaoftheStomach+1
Trials 1Status Active

2 / 3 pages

← PreviousNext →